2026 Q2 Portfolio Activity
In 2026 Q2, First Turn Management, LLC maintained a portfolio of 39 distinct positions. The most significant new addition was ASCENDIS PHARMA A/S, now representing 2.99% of the total fund value. They heavily accumulated shares in CYTOKINETICS INC, increasing the position by 85.9%. The fund also reduced its exposure to NUVALENT INC by 92.9%.
Position History
hover any row below to update
Loading…
Total Positions
39
Quarter
2026 Q2
Top Holding
RVMD (8.3%)
Top 10 Concentration
53.6%
Turnover Rate
23.4%
Sector HHI
0.18
Items per page:
Showing 1-39 of 39
First Turn Management, LLC Full Holdings List — 2026 Q2
| Stock | History | Sector / Type | Port % | Prev % | Rank / Prev | Conviction | Change | % Change | Influence | Shares | Mkt Value | Avg Cost | Price Held | 1st Owned | Source | Source Date | Date Reported | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
RVMD
REVOLUTION MEDI...
|
Healthcare | 8.32% | 5.09% |
#1
4
Prev: #5
|
5.8 |
—
|
-53,069 | -11.3% |
P
S
|
415,307 | $77,778,695 |
$41.65
+414.9%
|
2024 Q2 | 13F Filing | 2026-06-30 | 2026-08-14 | ||
|
ABVX
ABIVAX SA
|
Healthcare | 6.98% | 5.80% |
#2
Prev: #2
|
6.3 |
—
|
24,020 | 5.2% |
P
S
|
489,889 | $65,282,608 |
$100.96
+17.8%
|
2025 Q3 | 13F Filing | 2026-06-30 | 2026-08-14 | ||
|
AXSM
AXSOME THERAPEU...
|
Healthcare | 5.72% | 3.56% |
#3
9
Prev: #12
|
5.3 |
—
|
29,643 | 15.7% |
P
S
|
218,415 | $53,461,440 |
$104.55
+106.3%
|
2023 Q4 | 13F Filing | 2026-06-30 | 2026-08-14 | ||
|
ELVN
ENLIVEN THERAPE...
|
Healthcare | 5.18% | 2.73% |
#4
11
Prev: #15
|
5.6 |
—
|
330,521 | 53.0% |
P
S
|
954,360 | $48,433,770 | 2024 Q2 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
BBIO
BRIDGEBIO PHARM...
|
Healthcare | 5.05% | 5.77% |
#5
2
Prev: #3
|
3.0 |
—
|
-62,354 | -9.0% |
P
S
|
633,364 | $47,172,951 | 2024 Q3 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
ROIV
ROIVANT SCIENCE...
|
Healthcare | 5.04% | 3.68% |
#6
5
Prev: #11
|
4.0 |
—
|
140,948 | 11.8% |
P
S
|
1,331,066 | $47,106,426 | 2023 Q4 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
UTHR
UNITED THERAPEU...
|
Healthcare | 4.92% | 6.94% |
#7
6
Prev: #1
|
2.5 |
—
|
-19,794 | -18.9% |
P
S
|
84,932 | $46,018,706 | 2025 Q3 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
CYTK
CYTOKINETICS IN...
|
Healthcare | 4.81% | 2.09% |
#8
11
Prev: #19
|
4.9 |
—
|
243,712 | 85.9% |
P
S
|
527,412 | $44,930,228 | 2023 Q4 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
XENE
XENON PHARMACEU...
|
Healthcare | 3.88% | 5.11% |
#9
5
Prev: #4
|
1.6 |
—
|
-186,644 | -23.7% |
P
S
|
600,200 | $36,228,072 | 2023 Q4 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
CELC
CELCUITY INC
|
Healthcare | 3.68% | 2.69% |
#10
6
Prev: #16
|
4.5 |
—
|
118,523 | 56.3% |
P
S
|
329,101 | $34,430,547 | 2026 Q1 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
VRDN
VIRIDIAN THERAP...
|
Healthcare | 3.28% | 1.99% |
#11
12
Prev: #23
|
4.3 |
—
|
758,663 | 83.2% |
P
S
|
1,670,000 | $30,677,900 | 2025 Q4 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
INSM
INSMED INC
|
Healthcare | 3.01% | 4.54% |
#12
5
Prev: #7
|
3.2 |
—
|
15,376 | 6.2% |
P
S
|
263,851 | $28,131,794 | 2024 Q2 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
QURE
UNIQURE NV
|
Healthcare | 3.00% | 1.12% |
#13
19
Prev: #32
|
1.7 |
—
|
-6,564 | -1.1% |
P
S
|
608,925 | $28,047,086 | 2025 Q4 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
N/A
ASCENDIS PHARMA...
|
|
Unknown | 2.99% | — |
#14
Prev: #—
|
4.7 |
—
|
104,877 | — |
NEW
|
104,877 | $27,972,793 | — | 13F Filing | 2026-06-30 | 2026-08-14 | ||
|
PRAX
PRAXIS PRECISIO...
|
Healthcare | 2.99% | 1.53% |
#15
15
Prev: #30
|
4.2 |
—
|
41,087 | 96.8% |
P
S
|
83,528 | $27,964,339 | 2024 Q4 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
DNTH
DIANTHUS THERAP...
|
Healthcare | 2.98% | 2.07% |
#16
4
Prev: #20
|
3.7 |
—
|
64,850 | 29.4% |
P
S
|
285,771 | $27,856,957 | 2026 Q1 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
PCVX
VAXCYTE INC
|
Healthcare | 2.76% | — |
#17
Prev: #—
|
4.6 |
—
|
443,836 | — |
NEW
|
443,836 | $25,800,187 | 2023 Q4 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
MIRM
MIRUM PHARMACEU...
|
Healthcare | 2.73% | 4.13% |
#18
9
Prev: #9
|
1.1 |
—
|
-182,413 | -45.6% |
P
S
|
218,051 | $25,527,231 | 2023 Q4 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
PVLA
PALVELLA THERAP...
|
Healthcare | 2.56% | 2.06% |
#19
2
Prev: #21
|
3.0 |
—
|
8,357 | 5.6% |
P
S
|
156,450 | $23,908,689 | 2026 Q1 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
COGT
COGENT BIOSCIEN...
|
Healthcare | 2.49% | 4.07% |
#20
10
Prev: #10
|
1.0 |
—
|
-345,058 | -36.4% |
P
S
|
602,281 | $23,308,275 | 2025 Q4 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
ERAS
ERASCA INC
|
Healthcare | 2.39% | 1.57% |
#21
8
Prev: #29
|
3.5 |
—
|
354,082 | 40.8% |
P
S
|
1,221,721 | $22,381,929 | 2026 Q1 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
ORIC
ORIC PHARMACEUT...
|
Healthcare | 2.34% | 2.86% |
#22
8
Prev: #14
|
1.9 |
—
|
no change | no change |
P
S
|
2,017,284 | $21,847,186 | 2024 Q1 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
NAMS
NEWAMSTERDAM PH...
|
Healthcare | 2.11% | 2.00% |
#23
1
Prev: #22
|
1.3 |
—
|
24,161 | 4.3% |
P
S
|
582,497 | $19,740,823 | 2025 Q2 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
APGE
APOGEE THERAPEU...
|
Healthcare | 1.97% | 4.83% |
#24
18
Prev: #6
|
0.8 |
—
|
-374,948 | -73.0% |
P
S
|
138,822 | $18,425,844 | 2024 Q1 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
RYTM
RHYTHM PHARMACE...
|
Healthcare | 1.83% | — |
#25
Prev: #—
|
4.2 |
—
|
154,018 | — |
NEW
|
154,018 | $17,100,619 | 2025 Q4 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
INBX
INHIBRX BIOSCIE...
|
Healthcare | 1.67% | — |
#26
Prev: #—
|
4.2 |
—
|
164,783 | — |
NEW
|
164,783 | $15,613,189 | 2026 Q2 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
SRRK
SCHOLAR ROCK HL...
|
Healthcare | 1.60% | 2.45% |
#27
10
Prev: #17
|
0.6 |
—
|
-175,163 | -39.2% |
P
S
|
271,227 | $14,917,485 | 2025 Q4 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
ORKA
ORUKA THERAPEUT...
|
Healthcare | 1.58% | — |
#28
Prev: #—
|
4.1 |
—
|
155,343 | — |
NEW
|
155,343 | $14,783,993 | 2026 Q2 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
KYMR
KYMERA THERAPEU...
|
Healthcare | 1.26% | 2.37% |
#29
11
Prev: #18
|
0.5 |
—
|
-152,139 | -59.7% |
P
S
|
102,533 | $11,757,459 | 2025 Q3 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
SION
SIONNA THERAPEU...
|
Healthcare | 0.52% | — |
#30
Prev: #—
|
3.7 |
—
|
110,493 | — |
NEW
|
110,493 | $4,860,587 | 2026 Q2 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
NUVL
NUVALENT INC
|
Healthcare | 0.35% | 4.24% |
#31
23
Prev: #8
|
0.1 |
—
|
-344,046 | -92.9% |
P
S
|
26,298 | $3,247,803 | 2023 Q4 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
MLTX
MOONLAKE IMMUNO...
|
Healthcare | 0.00% | 0.66% |
Sold All 😨
(Was: #33) |
0.0 |
—
|
-315,563 | -100.0% |
CLOSED
|
— | $— | 2025 Q1 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
OLMA
OLEMA PHARMACEU...
|
Healthcare | 0.00% | 1.28% |
Sold All 😨
(Was: #31) |
0.0 |
—
|
-768,662 | -100.0% |
CLOSED
|
— | $— | 2025 Q4 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
NTRA
NATERA INC
|
Healthcare | 0.00% | 1.81% |
Sold All 😨
(Was: #28) |
0.0 |
—
|
-81,077 | -100.0% |
CLOSED
|
— | $— | 2024 Q3 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
VERA
VERA THERAPEUTI...
|
Healthcare | 0.00% | 1.90% |
Sold All 😨
(Was: #27) |
0.0 |
—
|
-422,023 | -100.0% |
CLOSED
|
— | $— | 2024 Q1 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
TERN
TERNS PHARMACEU...
|
Healthcare | 0.00% | 1.92% |
Sold All 😨
(Was: #26) |
0.0 |
—
|
-326,694 | -100.0% |
CLOSED
|
— | $— | 2025 Q4 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
FULC
FULCRUM THERAPE...
|
Healthcare | 0.00% | 1.93% |
Sold All 😨
(Was: #25) |
0.0 |
—
|
-2,256,109 | -100.0% |
CLOSED
|
— | $— | 2025 Q4 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
ASND
ASCENDIS PHARMA...
|
Healthcare | 0.00% | 1.95% |
Sold All 😨
(Was: #24) |
0.0 |
—
|
-76,300 | -100.0% |
CLOSED
|
— | $— | 2023 Q4 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
IDYA
IDEAYA BIOSCIEN...
|
Healthcare | 0.00% | 3.25% |
Sold All 😨
(Was: #13) |
0.0 |
—
|
-873,838 | -100.0% |
CLOSED
|
— | $— | 2023 Q4 | 13F Filing | 2026-06-30 | 2026-08-14 |
Showing 1-39 of 39 holdings